By Maitane Sardon
GlaxoSmithKline PLC said Monday that it has set targets to advance diversity in its senior leadership teams.
The British pharmaceutical company said it would aim to increase female representation at the vice president level and higher to at least 45% by 2025. It said 37% of these roles are currently held by women.
The company also said it would aim to have 30% ethnically diverse senior managers in the U.S. by 2025 from the current level of 23%. It will focus on increasing the percentage of Black and Hispanic or Latin American senior leaders, it said.
In the U.K., GlaxoSmithKline is targeting at least 18% ethnically diverse leaders by the end of 2025, from a current level of 11%.
"We have already made some good progress on our inclusion and diversity agenda, but there is still much more we can do," said Chief Executive Officer Emma Walmsley. "These new ambitions are the next step for us as we build a diverse workforce that represents the society we operate in and ultimately helps us provide more effective solutions for patients and consumers."
Write to Maitane Sardon at email@example.com
(END) Dow Jones Newswires
February 17, 2021 05:31 ET (10:31 GMT)Copyright (c) 2021 Dow Jones & Company, Inc.